These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17297441)

  • 1. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines.
    Igarashi T; Izumi H; Uchiumi T; Nishio K; Arao T; Tanabe M; Uramoto H; Sugio K; Yasumoto K; Sasaguri Y; Wang KY; Otsuji Y; Kohno K
    Oncogene; 2007 Jul; 26(33):4749-60. PubMed ID: 17297441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cisplatin sensitivity transcriptional factor and mitochondrial DNA maintenance protein].
    Uchiumi T; Knag D
    Rinsho Byori; 2009 Oct; 57(10):978-86. PubMed ID: 19928495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating transcription factor 4 increases the cisplatin resistance of human cancer cell lines.
    Tanabe M; Izumi H; Ise T; Higuchi S; Yamori T; Yasumoto K; Kohno K
    Cancer Res; 2003 Dec; 63(24):8592-5. PubMed ID: 14695168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized phospholipids regulate expression of ATF4 and VEGF in endothelial cells via NRF2-dependent mechanism: novel point of convergence between electrophilic and unfolded protein stress pathways.
    Afonyushkin T; Oskolkova OV; Philippova M; Resink TJ; Erne P; Binder BR; Bochkov VN
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1007-13. PubMed ID: 20185790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells.
    Hirano G; Izumi H; Kidani A; Yasuniwa Y; Han B; Kusaba H; Akashi K; Kuwano M; Kohno K
    Mol Cancer Res; 2010 Jun; 8(6):864-72. PubMed ID: 20530585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of autophagy by ATF4 in response to severe hypoxia.
    Rzymski T; Milani M; Pike L; Buffa F; Mellor HR; Winchester L; Pires I; Hammond E; Ragoussis I; Harris AL
    Oncogene; 2010 Aug; 29(31):4424-35. PubMed ID: 20514020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance.
    Jia Y; Zhang W; Liu H; Peng L; Yang Z; Lou J
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):377-85. PubMed ID: 21833590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microRNAs in drug-resistant ovarian cancer cells.
    Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
    Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines.
    Kashiwagi E; Izumi H; Yasuniwa Y; Baba R; Doi Y; Kidani A; Arao T; Nishio K; Naito S; Kohno K
    Cancer Sci; 2011 Feb; 102(2):382-6. PubMed ID: 21087353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib.
    Milani M; Rzymski T; Mellor HR; Pike L; Bottini A; Generali D; Harris AL
    Cancer Res; 2009 May; 69(10):4415-23. PubMed ID: 19417138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W; Liu G; Zheng J
    Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells.
    Wu ZZ; Lu HP; Chao CC
    Biochem Pharmacol; 2010 Jul; 80(2):262-76. PubMed ID: 20361941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line.
    Gu Y; Fan S; Xiong Y; Peng B; Zheng G; Yu Y; Ouyang Y; He Z
    FEBS Lett; 2011 Mar; 585(6):881-7. PubMed ID: 21334329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance.
    Cho JM; Manandhar S; Lee HR; Park HM; Kwak MK
    Cancer Lett; 2008 Feb; 260(1-2):96-108. PubMed ID: 18036733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate genes for cross-resistance against DNA-damaging drugs.
    Wittig R; Nessling M; Will RD; Mollenhauer J; Salowsky R; Münstermann E; Schick M; Helmbach H; Gschwendt B; Korn B; Kioschis P; Lichter P; Schadendorf D; Poustka A
    Cancer Res; 2002 Nov; 62(22):6698-705. PubMed ID: 12438269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.